Lensar (LNSR) Total Non-Current Liabilities (2019 - 2026)
Lensar (LNSR) posted quarterly Total Non-Current Liabilities of $40.8 million for Q1 2026, down 49.4% year-over-year from $80.7 million in Q1 2025, and down 50.66% quarter-over-quarter from $82.8 million in Q4 2025.
Lensar (LNSR) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Total Non-Current Liabilities for 8 consecutive years, with $40.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 49.4% year-over-year to $40.8 million; the TTM figure through Mar 2026 stood at $40.8 million (down 49.4% YoY), while the FY2025 annual figure was $82.8 million, up 365.05% from the prior year.
- Total Non-Current Liabilities fell to $40.8 million in Q1 2026 per LNSR's latest filing, from $82.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $82.8 million in Q4 2025 and bottomed at $10.4 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $30.2 million across 5 years, with a median of $20.0 million in 2024.
- Annual changes were most pronounced in 2025 — Total Non-Current Liabilities soared 516.69% — and 2026, when it sank 49.4%.
- Lensar's Total Non-Current Liabilities stood at $13.7 million in 2022, then increased by 1.89% to $14.0 million in 2023, then rose by 27.54% to $17.8 million in 2024, then soared by 365.05% to $82.8 million in 2025, then slumped by 50.66% to $40.8 million in 2026.
- Business Quant data shows LNSR's Total Non-Current Liabilities at $40.8 million in Q1 2026, $82.8 million in Q4 2025, and $81.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Lensar | 106.25 Mn | 92.68 Mn | 9.78 Mn | 25.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.85 Mn |
| Mar 31, 2026 | 40.83 Mn |
| Dec 31, 2025 | 82.76 Mn |
| Sep 30, 2025 | 81.42 Mn |
| Jun 30, 2025 | 32.44 Mn |
| Mar 31, 2025 | 80.70 Mn |
| Dec 31, 2024 | 17.80 Mn |
| Sep 30, 2024 | 13.20 Mn |
| Jun 30, 2024 | 23.72 Mn |
| Mar 31, 2024 | 20.02 Mn |
| Dec 31, 2023 | 13.95 Mn |
| Sep 30, 2023 | 20.16 Mn |
| Jun 30, 2023 | 24.19 Mn |
| Mar 31, 2023 | 12.52 Mn |
| Dec 31, 2022 | 13.69 Mn |
| Sep 30, 2022 | 12.22 Mn |
| Jun 30, 2022 | 13.80 Mn |
| Mar 31, 2022 | 10.44 Mn |
| Dec 31, 2021 | 11.52 Mn |
| Sep 30, 2021 | 10.97 Mn |